TipRanks
55% OFF
PC:IMMIT

Immitra Bio GmbH

Wagistrasse 18 Schlieren, Zürich 8952, CHhttps://immitrabio.com/Therapeutics

Immitra Bio GmbH is a biotechnology company developing a scalable in‑vivo genetic medicine platform to enable precise, durable, and safe gene modifications directly within hematopoietic (blood) stem cells. The company’s technology is designed to enable scalable, curative in‑vivo therapies by delivering targeted genetic modifications to blood stem cells for the treatment of monogenic and other hematologic disorders.

Leadership & Board

Key Executives

Founder
Jan Nelis
Founder
Amir Taheri-Ghahfarokhi
Founder
Jacob Corn
Current Number of Employees
6
Current LinkedIn Followers
2,378

Latest Estimated Valuation

Estimated Valuation
―
Total Amount Raised
$3M
Total Funding Rounds
1
Latest Funding Amount
$3M
Latest Funding Round
Pre-Seed
Post-Money Valuation
―

Employee Trend

Immitra Bio GmbH had 6 employees as of October 12, 2026. The number of employees increased by 0 (0.00%) week-over-week.

6Latest Employee Count
0(0.00%)Week-Over-Week Change
02468Aug 03, 2026Aug 17, 2026Aug 31, 2026Sep 14, 2026Sep 28, 2026Oct 12, 2026

Social Trend

Immitra Bio GmbH had 2,378 followers as of October 12, 2026. The number of followers increased by 12 (0.51%) week-over-week.

2,378Latest Followers Count
12(0.51%)Week-Over-Week Change
01,0002,0003,0004,000Aug 03, 2026Aug 17, 2026Aug 31, 2026Sep 14, 2026Sep 28, 2026Oct 12, 2026

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Jul 28, 2026Pre-Seed$3.00M―

Similar Companies

A snapshot of private companies similar to Immitra Bio GmbH, helping you discover and navigate related company profiles.

Related News and Analysis